FDA Approved: HORIZANT — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))

View source ↗

Summary

FDA approved a supplemental application for HORIZANT (gabapentin enacarbil) submitted by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia
• Restless Legs Syndrome

Drugs mentioned

• Horizant (gabapentin enacarbil)

Snippet

SUPPL AP for HORIZANT (GABAPENTIN ENACARBIL)